REMINDER: Our user survey closes TODAY, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-Cola HBC Regulatory News (CCH)

Share Price Information for Coca-Cola HBC (CCH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,724.00
Bid: 2,724.00
Ask: 2,726.00
Change: -6.00 (-0.22%)
Spread: 2.00 (0.073%)
Open: 2,726.00
High: 2,740.00
Low: 2,722.00
Prev. Close: 2,730.00
CCH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Composition of the Committees of the BoD

22 Jun 2021 13:55

RNS Number : 7376C
Coca-Cola HBC AG
22 June 2021
 

 

 

Coca-Cola HBC AG

Composition of the Committees of the Board of Directors of Coca-Cola HBC AG

Zug, Switzerland - 22 June 2021 - Coca-Cola HBC AG ("Coca-Cola HBC" or the "Company") announces today that following the election of the board members by the AGM the composition of the Board Committees will be as follows:

 

Audit and Risk Committee

Bill Douglas (Chair)

 

Olusola David-Borha

 

Alexandra Papalexopoulou

Nomination Committee

Reto Francioni (Chair)

 

Charlotte Boyle

 

Anna Diamantopoulou

Remuneration Committee

Charlotte J. Boyle (Chair)

 

Reto Francioni

 

Anna Diamantopoulou

Social Responsibility Committee

Anastasios I. Leventis (Chair)

 

Anna Diamantopoulou

 

Bruno Pietracci

 

This announcement is made pursuant to the Financial Conduct Authority's Listing Rule 9.6.11.

 Enquiries

Coca-Cola HBC Group

Investors and Analysts:

Joanna Kennedy Tel: +44 (0) 7802 427505

Investor Relations Director joanna.kennedy@cchellenic.com

 

Carla Fabiano Tel: +44 (0) 7808 215245

Investor Relations Manager carla.fabiano@cchellenic.com

 

Vasso Aliferi Tel: +41 (0) 79 610 7881

Investor Relations Manager vasso.aliferi@cchellenic.com

 

Media:

David Hart Tel: +41 (0) 41 726 0143

Group Communication Director david.hart@cchellenic.com

 

 

 

About Coca-Cola HBC 

Coca-Cola HBC AG, a growth-focused Consumer Packaged Goods business and strategic bottling partner of The Coca-Cola Company. We create value for all our stakeholders by supporting the socio-economic development of the societies in which we operate and we believe building a more positive environmental impact is integral to our future growth. Together, we and our customers serve more than 600 million consumers across a broad geographic footprint of 28 countries on 3 continents. Our portfolio is one of the strongest, broadest and most flexible in the beverage industry, offering consumer-leading partner brands in the sparkling, juice, water, sport, energy, plant-based, ready-to-drink tea, coffee, adult sparkling and premium spirits categories. These brands include Coca-Cola, Coca-Cola Zero, Schweppes, Kinley, Royal Bliss, Costa Coffee, Valser, Romerquelle, Fanta, Sprite, Powerade, FuzeTea, Dobry, Cappy, Monster and Adez. We foster an open and inclusive work environment amongst our more than 28,000 employees and we are ranked among the top sustainability performers in ESG benchmarks such as the Dow Jones Sustainability Indices, CDP, MSCI ESG and FTSE4Good.

 

Coca-Cola HBC has a premium listing on the London Stock Exchange (LSE:CCH) and is listed on the Athens Exchange (ATHEX:EEE). For more information, please visit https://www.coca-colahellenic.com/.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOADZGZVZZGGMZM
Date   Source Headline
8th May 20245:50 pmRNSTransaction in Own Shares
7th May 20245:29 pmRNSTransaction in Own Shares
3rd May 20245:25 pmRNSTransaction in Own Shares
3rd May 202412:46 pmRNSDirector/PDMR Shareholding
3rd May 202412:38 pmRNSDirector/PDMR Shareholding
2nd May 20245:41 pmRNSTransaction in Own Shares
2nd May 202412:40 pmRNSAthens Exchange trading date of ordinary shares
1st May 20245:47 pmRNSTransaction in Own Shares
1st May 202410:09 amRNSBlock listing Interim Review
1st May 20249:10 amRNSIssue of equity and total voting rights
30th Apr 20247:00 amRNSStrong start; reiterating 2024 guidance
19th Apr 20249:20 amRNSNotice of AGM
18th Apr 20244:21 pmRNSDirector/PDMR Shareholding
5th Apr 20242:17 pmRNSNotice of Results
2nd Apr 202411:12 amRNSIssue of equity and total voting rights
28th Mar 20245:55 pmRNSDirector/PDMR Shareholding
28th Mar 20245:47 pmRNSDirector/PDMR Shareholding
28th Mar 20245:42 pmRNSDirector/PDMR Shareholding
28th Mar 20245:26 pmRNSTransaction in Own Shares
27th Mar 20245:23 pmRNSTransaction in Own Shares
26th Mar 20245:05 pmRNSTransaction in Own Shares
26th Mar 20249:09 amRNSDirector/PDMR Shareholding
25th Mar 20245:10 pmRNSTransaction in Own Shares
22nd Mar 20245:27 pmRNSTransaction in Own Shares - Replacement
22nd Mar 20245:05 pmRNSTransaction in Own Shares
21st Mar 20245:40 pmRNSTransaction in Own Shares
20th Mar 20245:33 pmRNSTransaction in Own Shares
19th Mar 20245:20 pmRNSTransaction in Own Shares
19th Mar 20241:19 pmRNSDirector/PDMR Shareholding
18th Mar 20245:20 pmRNSTransaction in Own Shares
15th Mar 20246:25 pmRNSTransaction in Own Shares
15th Mar 20245:58 pmRNSAnnual Financial Report
14th Mar 20245:30 pmRNSTransaction in Own Shares
14th Mar 20243:04 pmRNSDirector/PDMR Shareholding
14th Mar 20242:56 pmRNSDirector/PDMR Shareholding
13th Mar 20245:20 pmRNSTransaction in Own Shares
12th Mar 20245:15 pmRNSTransaction in Own Shares
11th Mar 20245:50 pmRNSTransaction in Own Shares
8th Mar 20245:45 pmRNSTransaction in Own Shares
7th Mar 20245:20 pmRNSTransaction in Own Shares
6th Mar 20245:10 pmRNSTransaction in Own Shares
5th Mar 20245:15 pmRNSTransaction in Own Shares
4th Mar 20245:55 pmRNSTransaction in Own Shares
1st Mar 20245:15 pmRNSTransaction in Own Shares
1st Mar 20249:25 amRNSIssue of Equity and total voting rights
29th Feb 20245:25 pmRNSTransaction in Own Shares
29th Feb 20243:10 pmRNSDirector/PDMR Shareholding
29th Feb 20243:00 pmRNSDirector/PDMR Shareholding
29th Feb 20242:53 pmRNSDirector/PDMR Shareholding
28th Feb 20245:25 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.